Skip to content

Peripheral Relative Refractive Power of Orthokeratology Lenses

Effectiveness of Orthokeratology and Peripheral Retinal Refraction Changes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07294404
Enrollment
53
Registered
2025-12-19
Start date
2020-01-10
Completion date
2021-10-19
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia, Myopia; Refractive Error

Brief summary

Orthokeratology (OK) has been demonstrated to be an effective intervention for slowing axial elongation in children with myopia. The proposed mechanism of action is the induction of peripheral myopic defocus, which reduces relative peripheral hyperopia on the retina. This study aims to evaluate changes in relative peripheral retinal refraction before and after OK lens wear using wide-field multispectral retinal refractive topography. The study will also investigate the relationship between these retinal refractive changes and the effectiveness of OK in controlling axial elongation.

Interventions

All participants will be fitted with orthokeratology lenses of the same design. The primary objective is to assess changes in relative peripheral retinal refraction before and after lens wear.

Sponsors

Tianjin Eye Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
8 Years to 15 Years
Healthy volunteers
Yes

Inclusion criteria

* 8 to 15 years old * myopia of -4.00D or lower, * regular astigmatism ≤1.50D and non-regular astigmatism ≤1.00D * intraocular pressure ≤21mmHg * understand the purpose of the study and have good hygiene and regular follow-up

Exclusion criteria

* unilateral * immunocompromised subjects with systemic diseases (such as acute or chronic sinusitis, diabetes mellitus, Down syndrome, rheumatoid arthritis, psychiatric patients, etc.) * complicated with other eye diseases that affect OK lens wearing, such as dacryocystitis, blepharitis and other inflammation, glaucoma, etc. * BCVA less than 1.0 * children with corneal curvature less than 40.00D or higher than 46.00D.

Design outcomes

Primary

MeasureTime frameDescription
Changes in axial length growth(ALG)Change from baseline in axial length at 12 monthsAxial length will be measured using an ocular biometer (AL-Scan, NIDEK, Japan). Axial length growth (ALG) will be defined as the difference between the 1-year measurement and baseline.

Secondary

MeasureTime frameDescription
Change in Relative Peripheral Retinal RefractionBaseline (pre-lens wear), 1 month, 6 months, and 12 months after orthokeratology lens wear.Retinal refractive power will be measured using multispectral retinal refractive topography. Relative peripheral retinal refraction will be calculated as the difference between peripheral and central retinal refractive power. Changes from pre- to post-orthokeratology lens wear will be evaluated.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026